PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

Data collected through the study may be used to address a range of research questions and use cases and objectives, including but not limited to study * Creation of a cohort of psoriasis subjects to describe the clinical and patient-reported outcomes (PRO) and changes at 2,4, and 16 weeks after initiation of the advanced therapy. * Inform clinical decision making by subjects and treating providers. This will be enabled through the standardized data collection including validated patient-reported outcomes (PRO) and clinician-reported outcomes (ClinRO), and the recording of medication utilization data. * Describe subject characteristics (i.e. comorbidity, medication history, sociodemographic) at baseline. * For subjects with a dermatologist-confirmed diagnosis of psoriatic arthritis at baseline, to describe the joint pain and patient wellness.